The University of Louisville ExCITE (Expediting Commercialization, Innovation, Translation, and Entrepreneurship) program administers support by developing infrastructure for identifying technologies, allocating funding for product definition studies, providing access to early-stage development expertise and offering hands-on skills development in entrepreneurism.
ExCITE technologies must originate from the University of Louisville and be eligible for intellectual property protection (or have some other potential to return income to the program). There is no disease-specific requirement, but each application/proposal will be reviewed carefully for technical consistency and other criteria before funding is determined.
Applicants can request funding for anything that will make the technology more attractive to the private sector, including specific development studies that have been requested by potential investors, licensees or partners.
The purpose of the NIH Research Evaluation and Commercialization Hub (REACH) is to support proof-of-concept centers (hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health.
The long-term goals of the program are to foster commercialization success, economic development and entrepreneurial culture change at each hub institution.
Who you are
UofL faculty, staff or student with an entrepreneurial streak and an idea for an innovative health care technology.
What you get
- Up to $200,000 in grant funding;
- Support in commercialization process.
- Day, Month, Year